LabPulse.com

Lab News

Liquid biopsy enhances MRI studies of breast cancer patients
April 10, 2021 -- Adding liquid biopsy to magnetic resonance imaging (MRI) may improve the ability to gauge breast cancer treatment response, according to research presented April 10 at the American Association for Cancer Research annual meeting. Read More

Lucira Health assay spots 'double mutant' COVID-19 variant
April 9, 2021 -- Lucira Health said it can successfully identify the "double mutant" variant of COVID-19 with its Lucira molecular test kit. Read More

Hologic acquires Mobidiag for $795M
April 8, 2021 -- Hologic announced it has agreed to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation. Read More

Philips to partner with Ibex on digital pathology
April 8, 2021 -- Royal Philips is partnering with artificial intelligence software developer Ibex Medical Analytics to promote their digital pathology products to hospitals, health networks, and pathology labs worldwide. Read More

Nucleix secures $55M in funding for lung cancer test
April 7, 2021 -- Liquid biopsy company Nucleix has secured $55 million to advance Lung EpiCheck, an early detection lung cancer test based on methylation technology. Read More

Mologic lands NIH funding for COVID-19 rapid antigen self-test
April 6, 2021 -- Mologic said that its COVID-19 rapid antigen self-test for home use has been awarded funding under the U.S. National Institutes of Health Rapid Acceleration of Diagnostics initiative. Read More

FDA clears Binx Health's chlamydia, gonorrhea POC assay
April 2, 2021 -- The U.S. Food and Drug Administration is allowing Binx Health's IO Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) assay to be used at point-of-care (POC) settings, such as physician offices, community-based clinics, urgent care settings, and outpatient healthcare facilities, to test for chlamydia and gonorrhea. Read More

OptraScan launches new scanner
April 1, 2021 -- OptraScan announced it has launched a high-speed scanner called the OS-Ultra 320 designed to reduce workflow errors and scale up pathology laboratory operations. Read More

Delfi begins lung cancer study
April 1, 2021 -- Delfi Diagnostics announced the start of a national trial to evaluate its liquid biopsy test for early lung cancer detection. Read More

Menarini introduces multiple myeloma assay
April 1, 2021 -- Menarini Silicon Biosystems has launched the CellSearch Circulating Multiple Myeloma Cells Assay. The new test will assist pharmaceutical companies, contract research organizations, clinicians, and research scientists working on multiple myeloma. Read More

1 2 3…175 next »

Webinars/Videos